GENERAL COMMENTS
This is an interesting paper investigating the prevalence of PTSD in a sample of 171 patients visiting an outpatient TBI clinic in the UK. The prevalence of PTSD was rather high (21% -31.6%) and PTSD was associated with Marshall CT score, after adjusting for relevant confounders. The paper is well-written and clear and adds to the literature by analysing the prevalence of PTSD and the association with TBI severity in a relatively large number of patients. I however have some comments that the authors should consider before this paper can be published.
Introduction: after the second sentence (7.8%) a reference should be used.
Ethics: there is no mention on informed consent. This should be added.
Methods: could you explain why you used best GCS rather than admission GCS? A limitation of best GCS is that the number of patients with severe TBI could be underestimated.
Analyses: did you measure time since injury? This could be added as a covariate to the analysis. At this moment you included all patients up to 18 months following injury. However, the prevalence of PTSD might be very different 6 months and 18 months post-injury. If time since injury is not measured, this should be mentioned as a study limitation
Analyses: you used PTSD as a linear outcome measurement. This is adequate, but it might also be relevant to use a dichotomous outcome for PTSD (for example: PCL > 50). This could provide insight into whether the variables are associated with clinically relevant PTSD symptomathology. I would suggest that the authors add these analyses as online appendix. Tables: the structure of the tables could be more systematic. Also,  table 1 and table 2 
Abstract: "The association highlights the potential utility of routine neuroimaging in future research to predict psychiatric morbidity." This is unlikely. Psychiatric morbidity will be determined by clinical criteria, regardless of imaging findings. TBI patients will undergo imaging for clinical reasons, not to predict psychiatric morbidity. Also, this study looked only at CT scans, but MRI scanning provides much more information about structural brain injury, even though MRI scans are not routinely obtained in these patients.
The study population was selected from patients who were already attending an outpatient TBI clinic. As the authors acknowledge, this introduces a potentially important source of bias. References seem to be numbered in a different sequence than they appear in the text.
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GENERAL COMMENTS
The statistical analysis needs to be explained a little bit more. The rational behind performing the hierarchical multiple regression should be stated and why not running one multiple regression model. In the table 4, the value B should be defined. I understand it is the standardized beta coefficient? Is the confidence interval in the same table for B or Coefficient Beta?
The use of Prevalence term is tricky. I prefer that we add "Prevalence in our cohort."
VERSION 1 -AUTHOR RESPONSE
Revision #01 "Please revise your title to state the research question, study design, and setting (location). This is the preferred format for the journal."
'Post-Traumatic Stress Disorder in UK civilians with Traumatic Brain Injury: An observational study of TBI Clinic attendees to estimate PTSD prevalence and its relationship with radiological markers of brain injury severity' -Page 1
Reviewer One "This is an interesting paper investigating the prevalence of PTSD in a sample of 171 patients visiting an outpatient TBI clinic in the UK. The prevalence of PTSD was rather high (21% -31.6%) and PTSD was associated with Marshall CT score, after adjusting for relevant confounders. The paper is well-written and clear and adds to the literature by analysing the prevalence of PTSD and the association with TBI severity in a relatively large number of patients. I however have some comments that the authors should consider before this paper can be published."
Revision #02
"Introduction: after the second sentence (7.8%) a reference should be used."
Now clarified that this also is addressed in reference [1] -Page 3
Revision #3 "Ethics: there is no mention on informed consent. This should be added."
Mention of this has been added to the methods section alongside the details of ethical approval.
-Pages 5-6
Revision #4 "Methods: could you explain why you used best GCS rather than admission GCS? A limitation of best GCS is that the number of patients with severe TBI could be underestimated."
This comment to highlights the importance of more clearly explaining the rationale for using best GCS score, as it can more accurately predict long-term cognitive and functional outcomes. A comment to this effect and references have been added. However the potential for underestimation is a valid point and the limitations have also been updated in the discussion.
-Pages 6-7, Page 13.
Revision #5
"Analyses: did you measure time since injury? This could be added as a covariate to the analysis. At this moment you included all patients up to 18 months following injury. However, the prevalence of PTSD might be very different 6 months and 18 months post-injury. If time since injury is not measured, this should be mentioned as a study limitation"
As the relationships between PTSD and TBI are more clearly delineated in future research, the timing of injury and development of psychiatric symptoms would doubtless prove an interesting line of enquiry. Unfortunately it was outside the scope of thisanalysis and we have added this to the limitations accordingly. While it is a potentially important factor that can be measured precisely, the gradual onset of PTSD symptoms is often trickier to pin down. Furthermore its protracted course (sometimes with waxing and waning symptoms) would have complicated any conclusions that could be drawn about temporal relationship between TBI & PTSD within the limits of this cross-sectional design.
-Page 3
Revision #6 "Analyses: you used PTSD as a linear outcome measurement. This is adequate, but it might also be relevant to use a dichotomous outcome for PTSD (for example: PCL > 50). This could provide insight into whether the variables are associated with clinically relevant PTSD symptomatology. I would suggest that the authors add these analyses as online appendix."
Further explanation dichotomous PTSD scores has been added as well as the issues with different cut-offs. Dichotomous scores are used to produce the estimates of PTSD prevalence. However, at this stage the aim is to assess whether a novel association between symptom severity and radiological features exists. Using a cut-off threshold in the analysis risks missing subtle but genuine associations, and performing multiple analyses with different justifiable PCL cut-offs would be potentially problematic to interpret due to the risks of multiple statistical comparisons leading to spurious findings.
-Page 6
Revision #7 "Tables: the structure of the tables could be more systematic. Also, table 1 and table 2 could be combined."
The tables have been simplified and an explanation added, emphasising that table 2 is looking at the subset of 127 patients who could be included in the regression analysis, hence the separation from table 1.
-Page 8
Revision #8 "Study limitations: it could be added that this study did not have a control group. It would be interesting to assess the prevalence of PTSD in a group of comparable trauma control patients and see whether there are differences between TBI patients and patients with a trauma not involving the head"
The limitations have been updated to reflect this in the Discussion section, and the possibility of comparing TBI patients with extra-cranial trauma patients has been highlighted as an intriguing possibility for future study.
-Page 13
Reviewer Two
Revision #9 "Abstract: 'The association highlights the potential utility of routine neuroimaging in future research to predict psychiatric morbidity.' This is unlikely. Psychiatric morbidity will be determined by clinical criteria, regardless of imaging findings. TBI patients will undergo imaging for clinical reasons, not to predict psychiatric morbidity."
As rightly pointed out, imaging is undertaken for clinical reasons unrelated to psychiatric symptoms. The abstract has been clarified to emphasise what is stated in more detail latterly -that the study explores whether this routinely-collected clinical data could be repurposed and contribute (alongside other factors) to partially predict risk psychiatric morbidity. The abstract's phrasing: "potential utility of routine neuroimaging in future" reflects the tentative nature of this theory. Nonetheless, in response to this valid point about how psychiatric morbidity is determined, we have clarified that imaging data may prove useful as one of many risk factors for developing psychiatric symptoms in TBI patients. These changes should serve to ensure that the conclusions drawn do not appear overly strident.
-Page 2
Revision #10 "Also, this study looked only at CT scans, but MRI scanning provides much more information about structural brain injury, even though MRI scans are not routinely obtained in these patients."
Mention of this issue is now returned to the Discussion section as well as some comment that in future this may develop from opportunistic use of existing radiological data, toward potentially conducting specific imaging with a view to studying whether meaningful long-term outcomes can be predicted from it.
-Page 15
Revision #11 "The study population was selected from patients who were already attending an outpatient TBI clinic. As the authors acknowledge, this introduces a potentially important source of bias. Who determined GCS scores and Marshall scores? Did the assessors undergo a structured training program? Were audits performed to check accuracy?"
The GCS and Marshall scores were recorded by the neurosurgical team and more specifics regarding this have been added to the methods section. Recognising the radiological features pertinent to Marshall score (such as midline-shift) are essential skills for this clinical team, however specific audits of this practice were outside the scope of this research and that has now been added as a limitation. We have added these points to the Methodsand Discussion sections.
-Pages 7 and 13
Revision #12 "GCS score and Marshall score tend to move together, i.e., worse Marshall scores in patients with worse GCS scores. Did the statistical analysis account for this?"
Yes, separate analyses indicated the effect of each. An additional clarification of this point has been added at the end of the Results section and it is also mentioned in the discussion.
-Page 11
Revision #13 "'However since prior research suggests PTSD may be under-recognised in this group, relying on prior psychiatric diagnoses may not have been sufficient.' Meaning of this sentence is unclear.
Additional explanation added to clarify that previous research suggests PTSD is likely to be underdiagnosed in this group, hence the value in screening for psychiatric symptoms, as this may then indicate individuals for whom psychiatric assessment is warranted, even in the absence of a prior psychiatric diagnosis. This has been rephrased in the third paragraph of the Discussion for clarity.
-Page 12 Table 4 : data in parentheses in right-hand column need to be displayed differently. Combining hyphens (minus signs) and dashes is confusing. Table 4 , last line, right-hand column: "-1.86 (-0.01 ---0.21)" appears to be incorrect. The value -1.86 lies outside the range specified in parentheses.
Revision #14
Removed the confusing formatting and corrected the typo in the confidence intervals, the table now contains commas where appropriate instead of the additional hyphens.
-Page 10
Revision #15
References seem to be numbered in a different sequence than they appear in the text.
Additional references added as described above and numbers updated. However where a reference is referred to more than once, its numbering will be out of sequence on the second occasion.
-Page 16
Reviewer Three
Revision #16
The statistical analysis needs to be explained a little bit more. The rationale behind performing the hierarchical multiple regression should be stated and why not running one multiple regression model.
The rationale for performing a hierarchical regression has now been elaborated on more clearly as a test of the theory that brain injury severity may predict the dependent variable (PTSD severity), while acknowledging the need to rigorously control for multiple potentially confounding factors at the first level of the regression.
-Page 7
Revision #17
In the table 4, the value B should be defined. I understand it is the standardized beta coefficient? Is the confidence interval in the same table for B or Coefficient Beta?
The table has now been adjusted while still conforming to conventions for this analysis and journal style. It now shows more clearly that the first column is standardised Beta, and the latter columns refer to unstandardised B (with its confidence intervals and SE).
-Page 10
Revision #18
Clarified that this is an estimate based on the prevalence in our cohort in the Abstract and Results sections.
-Pages 2 and 7
